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Quality
Introduction
Fatigue is an important patient-reported outcome in many medical conditions (1, 2) and involves physical (e.g. feeling exhausted and tired), cognitive (e.g. impaired concentration), emotional (e.g. lack of motivation) and functional components (3) . It is often medically unexplained (4) and persistent (2) , and interferes with an individual's ability to function in important roles (e.g. work, family, social life, self-care) (5) . As a corollary, fatigue can have a major negative impact upon quality of life (QoL) (6) .
In chronic dialysis patients, fatigue is frequently reported as a pervasive and distressing symptom (7) (8) (9) . For many of these patients, kidney transplantation (KT) is the preferred modality of renal replacement therapy (10) . KT increases long term survival (10), improves QoL (11), demonstrates cost benefits (12) , and results in enhanced sense of well-being.
Consequently, it might be assumed that fatigue no longer feature as a major problem following KT, but in fact there has been very little research to either confirm or refute this assumption. Only one study has specifically examined fatigue following transplantation (13) , noting the symptom was reported in 59% of kidney transplant recipients (KTRs) and that it negatively impacted on virtually every aspect of the QoL (13) . Poor sleep quality, mood disturbance and raised body mass index were identified as significant predictors for posttransplant fatigue (13) . However, other potentially modifiable contributors to fatigue such as body composition, inflammation, renal function, and other biochemical markers were not examined and warrant further investigation.
The nature and severity of fatigue are shown in Table 3 , alongside normative data obtained from Lin's study (14) . Comparison were reanalysed after removal of this subscale, results were comparable after this exclusion (shown in parentheses in Table 4 ).
Factors predicting dimensions of fatigue
Linear regression analyses, to identify predictors of each fatigue dimension, were performed in 3 stages. First, univariate analyses tested the predictive value of each parameter individually. Second, multivariate analyses tested the independent prediction of all parameters. Third, the analysis was adjusted for anxiety, depression, and sleep quality, thereby focusing on clinical, anthropometric and laboratory parameters.
General Fatigue
The univariate analyses are shown in SDC, Table 5a . In multivariate analysis, only depression (β=2.8; 95% CI=1.9, 3.7; p<0.001) and inferior sleep quality (β=1.1; 95% CI=0.2, 1.9; p=0.01) were independently associated with GF (SDC, Figure 1 and SDC, Figure 2 
Physical Fatigue
The univariate analyses are shown in SDC, 
Reduced Activity
Reduced Motivation
The univariate models are shown in SDC, were independent predictors for RM.
Mental Fatigue
Finally, the univariate analyses predicting MF are shown in SDC, Compared to normative data from healthy population (14, 17) , KTRs suffer from higher levels of fatigue on all dimensions. In comparison to normative data from Lin (14) , fatigue levels in KTRs were similar to "chronically unwell" patients, defined as having chronic (≥ 6 months) unwellness with or without fatigue, but not meeting criteria for CFS (14) . Indeed, severity in certain domains, such as PF, RA and RM, approached that of CFS (14), further highlighting the burden of fatigue in KTRs. Of note, the level of MF was higher in KTRs compared to cancer patients with mild anaemia undergoing chemotherapy (17) , and chronic heart failure patients with and without anaemia (18) . Also, KTRs suffer from higher levels of PF, RA and RM compared to cancer patients without anaemia (17) . Physical aspects of The assessment of multiple domains of fatigue, and the measurement from the clinically validated HADS extends the findings of Rodrigue (13) where fatigue severity significantly correlated with a composite mood score incorporating depression, vigour, anger, confusion, anxiety and fatigue itself. The current study highlights the specific, independent importance of depression as a risk factor for all dimensions of fatigue except for MF. This exception is surprising as previous study on multiple sclerosis (MS) related fatigue found that depression was related to MF (20, 21) . However, depression and MF can occur independently or simultaneously (22) , this phenomenon has been demonstrated in stroke patients (22) . Many symptoms for depression and MF overlap, but the core symptoms are different. The lack of association in this study may be explained by the distinction between the core symptoms.
Depression is an illness or mood disorder with a variety of symptoms, the most defining being an inexplicable, enduring feeling of sadness, and loss of positive effect (23) . The collective symptoms may not manifest as MF, which is a psychobiological state caused by
prolonged periods of demanding cognitive activity such as concentration, attention and increased mental load (16). In MF, mental effort can only be sustained for a short timeframe, and recovery period is disproportionally long (22) . Accompanying symptoms include irritability, sensitivity to stress, concentration difficulties, and emotional instability (22) .
Anxiety was a significant predictor for MF, similar to other chronic conditions such as MS (21) . KTRs are subjected to several mental challenges, including fears about transplant rejection and the necessity to adhere to a complex regimen of immunosuppression therapy that may generate distressing side effects (24) . While inferior sleep quality may intuitively be expected to have a pervasive and broad effect on multiple aspects of fatigue (13) , a significant association was only observed for the GF dimension. This finding suggests that mere sleep difficulties do not explain a large spectrum of the fatigue complaints in KTRs, and interventions aiming to improve sleep quality may have limited effect on fatigue.
An important caveat with the interpretation of the associations between self-reported data, such as depression, sleep difficulties and symptoms of fatigue is that common-method variance (CMV) may partly drive the observed associations, and may account for 25% of shared variance (25). In CMV, patients high in negative affect (i.e. negative mood) perceive, remember and report more physical and psychological symptoms, and report those symptoms The association between inflammation and fatigue is particularly notable as the studied cohort consisted of clinically stable KTRs, without overt evidence of ongoing acute or chronic inflammatory conditions. Evidence from studies of healthy volunteers, elderly populations and other disease groups have shown that inflammatory cytokines possess potent neurological effects and are mediators of fatigue (13, (27) (28) (29) (30) . Modifying inflammation may therefore represent an attractive target in future studies.
The independent association between physical fatigue and reduced LTI is intuitively plausible, but not previously reported in KTRs. It replicates results from cancer-related fatigue (31), and fatigue associated with end-stage renal disease on haemodialysis (32, 33) .
Reduced muscle mass coupled with increased fat mass ("sarcopenic obesity") is a common characteristic of body composition following KT (34 of fatigue and SF-36 physical health subscale, which is a representation of self-perceived physical functioning. Recent studies reported that self-perceived physical functioning is significantly and positively correlated with physical activity level (37, 38). Although physical activity level was not measured in the current study, this finding suggests that striving to be physically active enhances functional capacity and improves self-perception of physical functioning, leading to improved fatigue and quality of life.
Although fatigue is a common and important symptom for patients on dialysis (7, 8) , the present results show, for the first time, a relationship between allograft dysfunction and physical fatigue in KTRs. Clinical strategies exist to improve allograft function (39) and fatigue may represent an important patient-reported outcome in future interventional studies.
Other non-modifiable, but important, risk factors for varying domains of fatigue included male, older age, ethnicity, comorbidity, and increasing time post-transplantation. The lack of association between haemoglobin level and fatigue is unsurprising as the results from the TREAT study (Trial to Reduce cardiovascular Events with Aranesp Therapy) (40) only showed a small improvement in fatigue with haemoglobin normalisation, using recombinant erythropoietin in non-transplant, diabetic, chronic kidney disease.
The use of immunosuppressive medication was not associated with fatigue in KTRs. Of relevance, no link between immunosuppression and fatigue was seen in previous studies of liver transplant recipients (19) and KTRs (13) .
This study has limitations that should be acknowledged. It is a single-centre study with a small sample size. The progression and regression of fatigue over time could not be evaluated due to the study design of cross-sectional nature. The results may not be representative of "sicker" patients within the transplanted population. It is recognised that hyperparathyroidism occurs in a substantial proportion of KTRs (17%) (41), with fatigue as a possible manifestation. Unfortunately, serum parathyroid hormone concentrations were not routinely measured in this study.
Whilst kidney transplantation is associated with a variety of benefits compared with dialysis, this study shows that fatigue remains a common and relevant problem in otherwise stable
KTRs. As the medical complexity of KTRs increases, it is important not to lose sight of important patient-reported outcomes such as fatigue. This study demonstrates potential targets for intervention, and future research should focus on evaluating the effectiveness and impact of such interventions upon fatigue and QoL.
Materials and Methods
Participants and study design
Stable KTRs beyond 1 year post-transplantation, with stable graft function (<10% increase in serum creatinine over preceding 6 months) were recruited to this cross-sectional study from Of 114 eligible patients approached, n=6 refused to participate and n=2 did not attend the research visit. Reasons for declining entry were work commitment (n=4) and participation in other studies (n=2). The study was approved by the local research ethics committee, and was conducted in accordance with the principles of the Declaration of Helsinki.
Patients attended the research visit following a 10-hour overnight fast. The order of tests was standardised. A fasting blood sampling was taken, followed by a light breakfast before bio- impedance body composition assessment, and self-completion of questionnaires under supervision of the researcher (see below).
Fatigue measurement
Severity and nature of fatigue were determined using the MFI-20, which is a 20-item self- 
Quality of life assessment
QoL was assessed using the Medical Outcomes Study Short Form 36 (SF-36) questionnaire, which generates the total score for QoL, as well as physical health and mental health subscores (see SDC, Materials and Methods for scoring and description of SF-36).
Factors associated with fatigue
Demographics and clinical parameters
Age, gender, marital status, ethnicity, and time post-transplantation were collected from patients' medical records. Smoking status (never smoked, current smoker, ex-smoker) and alcohol intake (units per week) were collected by questionnaire. Co-morbidity was assessed by Index of Co-Existing Disease (ICED), using the algorithm described by the Hemodialysis (HEMO) Study (43) , with data extracted from patients' medical records. Presence of diabetes, either pre-transplantation (pre-DM) or new onset diabetes after transplantation (NODAT), prior acute rejection episodes, and immunosuppressive medication usage were retrieved from patients' medical records.
Laboratory parameters
Fasting blood sample was taken for analysis of high sensitive C-reactive protein (hsCRP), haemoglobin (Hb) and estimated glomerular filtration rate (eGFR) derived using the 4-variable modification of diet in renal disease equation (44). 
Body composition
Body composition was assessed by multi-frequency bio-impedance measurement, using the body composition monitor to provide values for Lean Tissue Index (LTI) and Fat Tissue Index (FTI) (see SDC, Materials and Methods for explanation of bio-impedance measurement).
Self-reported outcome measures
Anxiety and Depression were assessed using the Hospital Anxiety and Depression Scale (HADS) (45) . Sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI) (46) .
See SDC, Materials and Methods for scoring and description of HADS and PSQI.
Statistical analysis
Statistical analysis was performed using STATA. Results are presented as mean ± standard deviation or median (interquartile range). Independent sample t-tests were used to compare continuous variables, and Pearson correlation coefficients to assess relationship.
Linear regression analysis was used to determine predictor variables associated with different domains of fatigue. The analyses were performed in two stages. Initially, the effect of each variable was examined in a series of univariate analyses. Subsequently, the joint effect of variables was examined in a multivariate analysis, using a backwards selection procedure to derive the final model. A type 1 error rate ≤5% (p≤0.05) was considered significant. Results The figures reported in SDC, Tables 5a, 5b, 5c, 5d and 5e, were regression coefficients or odds ratios, and their corresponding confidence intervals. The regression coefficients and odds ratios describe the change in fatigue for the described increase (or category) of the predictor variable.
